cyclo(prolylglycyl) has been researched along with Brain Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antipova, TA; Gudasheva, TA; Kolyasnikova, KN; Nikolaev, SV; Povarnina, PY | 1 |
| Barber, PA; Fan, D; Guan, J; Harris, P; Krishnamurthi, R | 1 |
2 other study(ies) available for cyclo(prolylglycyl) and Brain Ischemia
| Article | Year |
|---|---|
Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity.
Topics: Animals; Brain Ischemia; Cell Line; Glutamic Acid; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Peptides, Cyclic; Rats | 2016 |
Plasma cyclic glycine proline/IGF-1 ratio predicts clinical outcome and recovery in stroke patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Female; Glycine; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Peptides, Cyclic; Plasma; Proline; Stroke; Young Adult | 2019 |